Jeffrey H. Newcorn, MD
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY.
DELETE CME Institute Showcase
Emerging Therapies for Attention-Deficit/Hyperactivity Disorder
August 9, 2023
While patients with ADHD today still face numerous unmet needs, a number of newer pharmacologic agents and devices with potential advantages over traditional therapies have emerged and gained regulatory...
Original Research
Lisdexamfetamine for Sluggish Cognitive Tempo and Adult ADHD
June 29, 2021
Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce...
